Jeanne Freddura

Corporate Officer/Principal en COMMUNITY REDEVELOPMENT INC. .

Consumer Services

Finance

Health Technology

Cargos activos de Jeanne Freddura

Empresas	Cargo	Inicio	Fin
COMMUNITY REDEVELOPMENT INC.	Corporate Officer/Principal	02/02/2022	-

Empresas	Cargo	Inicio	Fin
Syntimmune, Inc. Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA.	Comptroller/Controller/Auditor	-	-

Cambridge College	Undergraduate Degree
Harvard University	Graduate Degree

Internacional

Estados Unidos

Operativa

Corporate Officer/Principal	1
Comptroller/Controller/Auditor	1
Undergraduate Degree	1

Sectorial

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	1
COMMUNITY REDEVELOPMENT INC.	Finance

Empresas privadas	1
Syntimmune, Inc. Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA.	Health Technology

Empresas privadas

Health Technology